Thomas E Richardson

This inventor holds 21 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 12 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Patent Gmbh, Renovion, Inc., Aerie Pharmaceuticals, Inc.. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas E Richardson. Retrieved from https://idiyas.com/inventor/thomas-e-richardson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 6)

% Patents Active = 57.1

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 12 (Patent Applications = 15)

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 93(Granted Patents)

Location History:

Durham, NC (US) (2008 - 2018)
Durham, SC (US) (2018)
Chapel Hill, NC (US) (2017 - 2023)

Company Filing History:

Aerie Pharmaceuticals, Inc.

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Ascorbic Acid Compositions

Calcium Channel Inhibitors

Benzamide Derivatives

Imidazole Compounds

Positive Allosteric Modulators

Dihydropyrazoles

Quinoxalines

Bicyclic Azaheterocyclics

Isoquinoline Compounds

Amino Azaheterocyclics

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12427180 - Treatment of respiratory tract diseases and infections with ascorbic acid compositions (2025-09-30),

2. 11602555 - Treatment of respiratory tract diseases and infections with ascorbic acid compositions (2023-03-14),

3. 11130750 - Calcium channel inhibitors (2021-09-28),

4. 10183935 - Benzamide derivatives as modulators of the follicle stimulating hormone (2019-01-22),

5. 10138233 - Imidazole compounds as modulators of FSHR and uses thereof (2018-11-27),

6. 9938268 - C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof (2018-04-10),

7. 9938262 - Benzamides (2018-04-10),

8. 9879004 - Substituted acetylene derivatives and their use as positive allosteric modulators of mGluR4 (2018-01-30),

9. 9775830 - Dihydropyrazoles (2017-10-03),

10. 9763938 - Substituted quinoxalines as positive allosteric modulators of mGluR4 (2017-09-19),

11. 9708321 - Spiro-quinazolinone derivatives and their use as positive allosteric modulators of mGluR4 (2017-07-18),

12. 9517227 - Dihydropyrazoles (2016-12-13),

13. 9498475 - Benzamides (2016-11-22),

14. 9409897 - Benzamide derivatives as modulators of the follicle stimulating hormone (2016-08-09),

15. 9181226 - Benzamides (2015-11-10),

Title: The Inventor Thomas E Richardson: Pioneering Innovations in Durham

Introduction: Thomas E Richardson is a distinguished inventor based in Durham, NC, known for his groundbreaking contributions to various fields.

Latest Patents: Thomas E Richardson holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Thomas E Richardson has been at the forefront of innovation, leading research and development teams to create cutting-edge solutions.

Collaborations: Throughout his career, Thomas E Richardson has collaborated with top universities, research institutions, and leading companies to bring his inventions to life, solidifying his reputation as a visionary inventor.

Conclusion: Thomas E Richardson's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.